Carmen Bergom1, Tracy Kelly1, Meena Bedi1, Hina Saeed1, Phillip Prior1, Lisa E Rein2, Aniko Szabo2, J Frank Wilson1, Adam D Currey1, Julia White3. 1. Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin. 2. Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin. 3. Department of Radiation Oncology, James Cancer Hospital, Ohio State University Comprehensive Cancer Center, Columbus, Ohio. Electronic address: Julia.White@osumc.edu.
Abstract
PURPOSE: Obesity, as measured by the body mass index (BMI), is a risk factor for distant recurrence and decreased survival in breast cancer. We sought to determine whether the BMI correlated with local recurrence and reduced survival in a cohort of predominantly obese women treated with breast conservation therapy. METHODS AND MATERIALS: From 1998 to 2010, 154 women with early-stage invasive breast cancer and 39 patients with ductal carcinoma in situ underwent prone whole breast irradiation. Cox proportional hazards regression, Kaplan-Meier methods with the log-rank test, and multivariate analysis were used to explore the association of the outcomes with the BMI. RESULTS: The median patient age was 60 years, and the median follow-up duration was 73 months. The median BMI was 33.2 kg/m(2); 91% of the patients were overweight (BMI ≥25 kg/m(2)) and 69% of the patients were clinically obese (BMI ≥30 kg/m(2)). The BMI was significantly associated with the locoregional recurrence-free interval for patients with invasive cancer and ductal carcinoma in situ (hazard ratio [HR], 1.09; P=.047). Also, a trend was seen for increased locoregional recurrence with a higher BMI (P=.09) for patients with invasive disease, which was significant when examining the outcomes with a BMI stratified by the median value of 33.2 kg/m(2) (P=.008). A greater BMI was also significantly associated with decreased distant recurrence-free interval (HR, 1.09; P=.011) and overall survival (HR, 1.09; P=.004); this association remained on multivariate analysis (distant recurrence-free interval, P=.034; overall survival, P=.0007). CONCLUSIONS: These data suggest that the BMI might affect the rate of locoregional recurrence in breast cancer patients. A higher BMI predicted a worse distant recurrence-free interval and overall survival. The present investigation adds to the increasing evidence that BMI is an important prognostic factor in early-stage breast cancer treated with breast conservation therapy.
PURPOSE:Obesity, as measured by the body mass index (BMI), is a risk factor for distant recurrence and decreased survival in breast cancer. We sought to determine whether the BMI correlated with local recurrence and reduced survival in a cohort of predominantly obesewomen treated with breast conservation therapy. METHODS AND MATERIALS: From 1998 to 2010, 154 women with early-stage invasive breast cancer and 39 patients with ductal carcinoma in situ underwent prone whole breast irradiation. Cox proportional hazards regression, Kaplan-Meier methods with the log-rank test, and multivariate analysis were used to explore the association of the outcomes with the BMI. RESULTS: The median patient age was 60 years, and the median follow-up duration was 73 months. The median BMI was 33.2 kg/m(2); 91% of the patients were overweight (BMI ≥25 kg/m(2)) and 69% of the patients were clinically obese (BMI ≥30 kg/m(2)). The BMI was significantly associated with the locoregional recurrence-free interval for patients with invasive cancer and ductal carcinoma in situ (hazard ratio [HR], 1.09; P=.047). Also, a trend was seen for increased locoregional recurrence with a higher BMI (P=.09) for patients with invasive disease, which was significant when examining the outcomes with a BMI stratified by the median value of 33.2 kg/m(2) (P=.008). A greater BMI was also significantly associated with decreased distant recurrence-free interval (HR, 1.09; P=.011) and overall survival (HR, 1.09; P=.004); this association remained on multivariate analysis (distant recurrence-free interval, P=.034; overall survival, P=.0007). CONCLUSIONS: These data suggest that the BMI might affect the rate of locoregional recurrence in breast cancerpatients. A higher BMI predicted a worse distant recurrence-free interval and overall survival. The present investigation adds to the increasing evidence that BMI is an important prognostic factor in early-stage breast cancer treated with breast conservation therapy.
Authors: T A Buchholz; S L Tucker; J Erwin; D Mathur; E A Strom; M D McNeese; G N Hortobagyi; M Cristofanilli; F J Esteva; L Newman; S E Singletary; A U Buzdar; K K Hunt Journal: J Clin Oncol Date: 2001-04-15 Impact factor: 44.544
Authors: Michelle Shayne; Jeffrey Crawford; David C Dale; Eva Culakova; Gary H Lyman Journal: Breast Cancer Res Treat Date: 2006-05-17 Impact factor: 4.872
Authors: Pamela J Goodwin; Marguerite Ennis; Mala Bahl; I George Fantus; Kathleen I Pritchard; Maureen E Trudeau; Jarley Koo; Nicky Hood Journal: Breast Cancer Res Treat Date: 2008-04-25 Impact factor: 4.872
Authors: T J Key; P N Appleby; G K Reeves; A Roddam; J F Dorgan; C Longcope; F Z Stanczyk; H E Stephenson; R T Falk; R Miller; A Schatzkin; D S Allen; I S Fentiman; T J Key; D Y Wang; M Dowsett; H V Thomas; S E Hankinson; P Toniolo; A Akhmedkhanov; K Koenig; R E Shore; A Zeleniuch-Jacquotte; F Berrino; P Muti; A Micheli; V Krogh; S Sieri; V Pala; E Venturelli; G Secreto; E Barrett-Connor; G A Laughlin; M Kabuto; S Akiba; R G Stevens; K Neriishi; C E Land; J A Cauley; L H Kuller; S R Cummings; K J Helzlsouer; A J Alberg; T L Bush; G W Comstock; G B Gordon; S R Miller; C Longcope Journal: J Natl Cancer Inst Date: 2003-08-20 Impact factor: 13.506
Authors: Natansh D Modi; Jin Quan Eugene Tan; Andrew Rowland; Bogda Koczwara; Ahmad Y Abuhelwa; Ganessan Kichenadasse; Ross A McKinnon; Michael D Wiese; Michael J Sorich; Ashley M Hopkins Journal: NPJ Breast Cancer Date: 2021-03-22
Authors: Emily N Devericks; Meredith S Carson; Lauren E McCullough; Michael F Coleman; Stephen D Hursting Journal: Cancer Metastasis Rev Date: 2022-06-25 Impact factor: 9.237
Authors: Soo Young Lee; Chang Hyun Kim; Young Jin Kim; Han Deok Kwak; Jae Kyun Ju; Hyeong Rok Kim Journal: Ann Surg Treat Res Date: 2018-02-26 Impact factor: 1.859